Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Delcath Systems Inc. (DCTH)

12.4   -0.36 (-2.82%) 08-13 16:00
Open: 12.65 Pre. Close: 12.76
High: 12.6872 Low: 12.16
Volume: 36,031 Market Cap: 48M
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers. The company's investigational products include melphalan hydrochloride for Injection for use with the Delcath hepatic delivery system to administer high-dose chemotherapy to the liver. Its clinical development program consists of FOCUS Trial for the patients with hepatic dominant ocular melanoma; and ALIGN Trial that is in Phase 3 clinical trial for intrahepatic cholangiocarcinoma. It also offers melphalan hydrochloride under the Delcath Hepatic CHEMOSAT Delivery System for Melphalan name in Europe. The company was founded in 1988 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.695 - 12.781 12.781 - 12.852
Low: 11.999 - 12.081 12.081 - 12.149
Close: 12.279 - 12.413 12.413 - 12.524

Technical analysis

as of: 2020-08-13 4:33:11 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 15.28     One year: 17.85
Support: Support1: 10.31    Support2: 8.60
Resistance: Resistance1: 13.08    Resistance2: 15.28
Pivot: 12.47
Moving Average: MA(5): 12.65     MA(20): 12.22
MA(100): 10.02     MA(250): 27.23
MACD: MACD(12,26): 0.75     Signal(9): 0.83
Stochastic oscillator: %K(14,3): 83.51     %D(3): 87.65
RSI: RSI(14): 58.93
52-week: High: 95.90  Low: 5.15  Change(%): -81.9
Average Vol(K): 3-Month: 6665  10-Days: 4061

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
DCTH has closed above bottom band by 45.1%. Bollinger Bands are 62.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to DCTH's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 13 Aug 2020
Delcath Systems, Inc. (DCTH) CEO John Purpura on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha

Thu, 13 Aug 2020
Delcath Systems, Inc. Announces Second Quarter 2020 Results - GlobeNewswire

Thu, 13 Aug 2020
Earnings Scheduled For August 13, 2020 - Yahoo Finance

Mon, 03 Aug 2020
Delcath to Present at Canaccord Genuity 40th Annual Growth Conference - GlobeNewswire

Mon, 20 Jul 2020
80 Biggest Movers From Friday - Benzinga

Tue, 26 May 2020
Delcath Announces Leadership Transition Nasdaq:DCTH - GlobeNewswire

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Other OTC
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. (M) 4
Shares Float (M) 3
% Held by Insiders 0.94
% Held by Institutions 0.08
Shares Short (K) 55
Shares Short P. Month (K) 17

Stock Financials

EPS -496.640
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) -110.000
Profit Margin
Operating Margin -1203.80
Return on Assets (ttm) -151.4
Return on Equity (ttm)
Qtrly Rev. Growth 8.9
Gross Profit (p.s.) 0.221
Sales Per Share 0.411
EBITDA (p.s.) -4.913
Qtrly Earnings Growth
Operating Cash Flow (M) -26
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -0.02
PEG Ratio
Price to Book value -0.11
Price to Sales 30.15
Price to Cash Flow -1.84

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.